Briacell Therap (BCTX) Competitors $12.40 -0.24 (-1.90%) Closing price 04:00 PM EasternExtended Trading$12.26 -0.14 (-1.13%) As of 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCTX vs. DARE, CVKD, RNTX, KZR, PASG, FBLG, MIRA, XCUR, ENLV, and MBRXShould you be buying Briacell Therap stock or one of its competitors? The main competitors of Briacell Therap include Dare Bioscience (DARE), Cadrenal Therapeutics (CVKD), Rein Therapeutics (RNTX), Kezar Life Sciences (KZR), Passage Bio (PASG), FibroBiologics (FBLG), MIRA Pharmaceuticals (MIRA), Exicure (XCUR), Enlivex Therapeutics (ENLV), and Moleculin Biotech (MBRX). These companies are all part of the "pharmaceutical products" industry. Briacell Therap vs. Its Competitors Dare Bioscience Cadrenal Therapeutics Rein Therapeutics Kezar Life Sciences Passage Bio FibroBiologics MIRA Pharmaceuticals Exicure Enlivex Therapeutics Moleculin Biotech Briacell Therap (NASDAQ:BCTX) and Dare Bioscience (NASDAQ:DARE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment. Does the media prefer BCTX or DARE? In the previous week, Dare Bioscience had 1 more articles in the media than Briacell Therap. MarketBeat recorded 4 mentions for Dare Bioscience and 3 mentions for Briacell Therap. Dare Bioscience's average media sentiment score of 1.09 beat Briacell Therap's score of 0.47 indicating that Dare Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Briacell Therap 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Dare Bioscience 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, BCTX or DARE? Briacell Therap has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Dare Bioscience has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Do insiders and institutionals believe in BCTX or DARE? 15.4% of Briacell Therap shares are held by institutional investors. Comparatively, 6.7% of Dare Bioscience shares are held by institutional investors. 5.7% of Briacell Therap shares are held by company insiders. Comparatively, 4.8% of Dare Bioscience shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, BCTX or DARE? Dare Bioscience has lower revenue, but higher earnings than Briacell Therap. Dare Bioscience is trading at a lower price-to-earnings ratio than Briacell Therap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriacell TherapN/AN/A-$4.79M-$83.18-0.15Dare Bioscience-$17.70K-1,614.46-$4.05M-$2.14-0.99 Do analysts recommend BCTX or DARE? Briacell Therap currently has a consensus target price of $320.00, suggesting a potential upside of 2,480.65%. Dare Bioscience has a consensus target price of $10.00, suggesting a potential upside of 371.70%. Given Briacell Therap's higher probable upside, equities analysts plainly believe Briacell Therap is more favorable than Dare Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Briacell Therap 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Dare Bioscience 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is BCTX or DARE more profitable? Dare Bioscience's return on equity of 0.00% beat Briacell Therap's return on equity.Company Net Margins Return on Equity Return on Assets Briacell TherapN/A -479.97% -182.26% Dare Bioscience N/A N/A -103.70% SummaryDare Bioscience beats Briacell Therap on 8 of the 14 factors compared between the two stocks. Get Briacell Therap News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBriacell TherapMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.43M$3.32B$6.01B$10.23BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-0.1522.1185.3526.57Price / SalesN/A416.63582.95179.01Price / CashN/A47.1938.3262.20Price / Book-0.5610.2112.726.53Net Income-$4.79M-$52.40M$3.30B$275.87M7 Day Performance-5.20%0.90%1.07%-1.40%1 Month Performance60.00%12.36%7.61%5.16%1 Year Performance-91.82%30.17%79.71%31.51% Briacell Therap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBriacell Therap2.3132 of 5 stars$12.40-1.9%$320.00+2,480.6%-90.9%$8.43MN/A-0.158Analyst ForecastDAREDare Bioscience1.7938 of 5 stars$2.10+0.5%$10.00+376.2%-31.6%$28.17M$10K-0.9830Positive NewsAnalyst ForecastCVKDCadrenal Therapeutics2.5639 of 5 stars$13.83+3.1%$32.00+131.4%+18.7%$27.47MN/A-1.564Analyst ForecastRNTXRein Therapeutics3.1023 of 5 stars$1.15-0.4%$10.00+773.4%N/A$26.80MN/A-0.439News CoveragePositive NewsAnalyst ForecastKZRKezar Life Sciences3.896 of 5 stars$3.90+8.6%$9.00+130.8%-49.1%$26.29M$7M-0.4060Positive NewsAnalyst ForecastHigh Trading VolumePASGPassage Bio3.61 of 5 stars$8.03-1.4%$75.67+842.3%-23.8%$25.88MN/A-0.44130Analyst ForecastGap UpFBLGFibroBiologics2.3751 of 5 stars$0.55-10.8%$12.67+2,219.1%-81.1%$25.64MN/A-1.5210Analyst ForecastHigh Trading VolumeMIRAMIRA Pharmaceuticals0.954 of 5 stars$1.36+2.3%N/A+22.9%$25.36MN/A-2.782Analyst ForecastXCURExicure1.6339 of 5 stars$4.09+4.9%N/A+135.7%$24.64M$500K-1.0550Analyst ForecastENLVEnlivex Therapeutics2.8412 of 5 stars$1.04+3.0%$10.00+861.5%-23.7%$24.54MN/A-1.7970Analyst ForecastMBRXMoleculin Biotech3.0366 of 5 stars$0.53+8.9%$4.00+654.7%-79.8%$24.10MN/A0.0020Analyst Forecast Related Companies and Tools Related Companies DARE Alternatives CVKD Alternatives RNTX Alternatives KZR Alternatives PASG Alternatives FBLG Alternatives MIRA Alternatives XCUR Alternatives ENLV Alternatives MBRX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Briacell Therap Please log in to your account or sign up in order to add this asset to your watchlist. Share Briacell Therap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
